SINGAPORE: Economic ties between Singapore and Guangdong remain robust, with their bilateral trade in 2022 surging to a record high and cementing the latter’s position as Singapore’s top Chinese provincial trading partner for the 34th year.
27 June 2023, Lion TCR, a clinical-stage T-cell immunotherapy company, is thrilled to announce the successful completion of its USD 40 million Series B2 financing round. Guangzhou Industrial Investment and Capital Operation Holding Group Ltd. led the financing with participation from Guangzhou Guoju Investment and CSPC NARD Capital Fund. The funds raised will be used primarily to support Lion TCR's clinical trials on hepatitis B virus (HBV)-specific TCR T cell therapy, while also facilitating th